Results 31 to 40 of about 802,581 (339)

Stereotactic Body Radiation Therapy for Pediatric, Adolescent, and Young Adult Patients With Osteosarcoma: Local Control Outcomes With Dosimetric Analysis

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background/Objectives Osteosarcoma is a radioresistant tumor that may benefit from stereotactic body radiation therapy (SBRT) for locoregional control in metastatic/recurrent disease. We report institutional practice patterns, outcomes, toxicity, and failures in osteosarcoma patients treated with SBRT.
Jenna Kocsis   +13 more
wiley   +1 more source

Dysphagia handicap index and fibre-optic endoscopic examination of swallowing in assessment of dysphagia

open access: yesThe Egyptian Journal of Otolaryngology, 2023
Oropharyngeal dysphagia is a swallowing disorder characterized by difficulty in transferring foods and/or liquids from the oral cavity to the stomach, affecting safe oral feeding. The main complications caused by dysphagia are tracheobronchial aspiration,
Nihal Hisham Abdelhamid   +1 more
doaj   +1 more source

Building on Julian Tudor Hart's example of anticipatory care [PDF]

open access: yes, 2010
The prevention and delay of chronic disease is an increasing priority in all advanced health-care systems, but sustainable, effective and equitable approaches remain elusive.
O'Donnell, C.A   +2 more
core   +1 more source

Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio‐Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Neuroblastoma (NB) with central nervous system (CNS) metastases is rare at diagnosis, but occurs more often during relapse/progression. Patients with CNS metastases face a dismal prognosis, with no standardized curative treatment available.
Vicente Santa‐Maria Lopez   +13 more
wiley   +1 more source

General practitioners' willingness to pay for continuing medical education in a fee-for-service universal coverage health care system [article] [PDF]

open access: yes, 2014
: Background: Sponsoring of medical meetings by life science companies has led to reduced participation fees for physicians but questions potential drawbacks. Ongoing discussions are proposing to ban such sponsoring which may increase participation fees.
Auer, R.   +4 more
core   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

The Research on the Outpatient Cost Adjustment Framework of the Urban Workers in a Southern China City During 2013 to 2015

open access: yesInquiry: The Journal of Health Care Organization, Provision, and Financing, 2019
Based on a large amount of data, the study aimed to analyze all expenses of outpatients in a southern China city from 2013 to 2015. It draws a conclusion that the total cost of outpatient has increased in the past 3 years, and various cost indexes either
Na Wang Msc   +4 more
doaj   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Honorários de um cirurgião na Justiça (Vila Boa de Goiás, 1801) A surgeon's fees in court (Vila Boa de Goiás, 1801)

open access: yesHistória, Ciências, Saúde: Manguinhos, 2012
Estuda-se a ação judicial de cobrança de honorários, proposta em Vila Boa de Goiás (1801), pelo cirurgião-mor André Villela da Cunha Roza, sendo ré a senhora Joanna da Fonseca Coutinha. Enfoca-se a prestação de assistência médica aos escravos, a escassez
Lena Castello Branco Ferreira de Freitas
doaj  

Home - About - Disclaimer - Privacy